Aadi Bioscience Inc’s recent filing unveils that its insider BALL BRYAN unloaded Company’s shares for reported $5045.0 on Mar 03 ’25. In the deal valued at $2.35 per share,2,147 shares were sold. As a result of this transaction, BALL BRYAN now holds 102,853 shares worth roughly $0.2 million.
Then, Giacobello Scott M. sold 2,806 shares, generating $6,594 in total proceeds. Upon selling the shares at $2.35, the CHIEF FINANCIAL OFFICER now owns 23,944 shares.
Before that, Lennon David James sold 5,690 shares. Aadi Bioscience Inc shares valued at $13,372 were divested by the CHIEF EXECUTIVE OFFICER at a price of $2.35 per share. As a result of the transaction, Lennon David James now holds 33,429 shares, worth roughly $64517.97.
Piper Sandler downgraded its Aadi Bioscience Inc [AADI] rating to a Neutral from a an Overweight in a research note published on August 27, 2024; the price target was decreased to $1.75 from $5. A number of analysts have revised their coverage, including TD Cowen’s analysts, who decreased its forecast for the stock in late August from “a Buy” to “a Hold”. Jefferies also remained covering AADI and has decreased its forecast on August 21, 2024 with a “Hold” recommendation from previously “Buy” rating. H.C. Wainwright revised its rating on December 15, 2023. It rated AADI as “a Neutral” which previously was an “a Buy”.
Price Performance Review of AADI
On Tuesday, Aadi Bioscience Inc [NASDAQ:AADI] saw its stock unchanged to $1.93. Over the last five days, the stock has lost -16.27%. Aadi Bioscience Inc shares have fallen nearly -38.83% since the year began. Nevertheless, the stocks have fallen -13.06% over the past one year. While a 52-week high of $3.81 was reached on 01/08/25, a 52-week low of $1.21 was recorded on 03/11/25. SMA at 50 days reached $2.8319, while 200 days put it at $2.1123.
Levels Of Support And Resistance For AADI Stock
The 24-hour chart illustrates a support level at 1.8667, which if violated will result in even more drops to 1.8033. On the upside, there is a resistance level at 1.9767. A further resistance level may holdings at 2.0233. The Relative Strength Index (RSI) on the 14-day chart is 24.61, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.4085, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.38%. Stochastics %K at 7.10% indicates the stock is a buying.
The most recent change occurred on January 11, 2022 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $45 price target.
